Globus Medical earnings were $535.4M for the trailing 12 months ending Jun 30, 2026, with 51% growth year over year. The latest GMED earnings report on Jun 30, 2026 announced Q2 2026 earnings of $151.6M, up 21.9% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GMED reported annual earnings of $537.9M, with 422.3% growth.
GMED past earnings growth
How has GMED's earnings growth performed historically?
On GMED's earnings call on Aug 6, 2026, Globus Medical (NYSE: GMED) reported Q2 2026 earnings per share (EPS) of $1.12, up 25.33% year over year. Total GMED earnings for the quarter were $151.57 million. In the same quarter last year, Globus Medical's earnings per share (EPS) was $1.50.
As of the last Globus Medical earnings report, Globus Medical is currently profitable. Globus Medical's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $535.43 million, a 50.13% increase year over year.
What was GMED's earnings growth in the past year?
As of Globus Medical's earnings date in Aug 6, 2026, Globus Medical's earnings has grown 50.95% year over year. This is 55.16 percentage points higher than the US Medical Devices industry earnings growth rate of -4.21%. GMED earnings in the past year totalled $535.43 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.